Dr. Xun Yang 杨迅
Chief Physician
Department of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of lung cancer, esophageal cancer, and mediastinal tumors. Diagnosis and minimally invasive treatment of pulmonary nodules.
Dr. Yang graduated from China Medical University in 1998 and holds a Master’s degree in Surgery from Zhejiang University. After one year of basic research at the University of Tokyo, Dr. Yang has practiced thoracic surgical oncology for over 20 years, with experience in treating lung, esophageal, mediastinal, cardia, and gastric cancers.
Name order: in Chinese the family name comes first (Yang Xun). Papers usually list the name as Xun Yang or Yang X.
Selected publications
43 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Bosn J Basic Med Sci, 2021 (senior author): The preoperative hemoglobin, albumin, lymphocyte and platelet (HALP) score is a useful predictor in patients with resectable esophageal squamous cell carcinoma. PubMed 33974528
- Oncol Lett, 2020 (senior author): SUMO4 small interfering RNA attenuates invasion and migration via the JAK2/STAT3 pathway in non-small cell lung cancer cells. PubMed 32968447
- Rev Invest Clin, 2020 (senior author): A NOVEL PROGNOSTIC INDEX IN PATIENTS WITH RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: FIBRINOGEN/PREALBUMIN RATIO. PubMed 32132740
- J Oncol, 2019 (senior author): C-Reactive Protein to Prealbumin Ratio (CPR): A Novel Inflammatory-Nutritional Prognostic Factor for Predicting Cancer-Specific Survival (CSS) and Overall Survival (OS) in Patients with Resectable Esophageal Squamous Cell Carcinoma. PubMed 31379941
- Oncotarget, 2017 (senior author): Combination of c-reactive protein and squamous cell carcinoma antigen in predicting postoperative prognosis for patients with squamous cell carcinoma of the esophagus. PubMed 28968977
- Medicine (Baltimore), 2017 (senior author): Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. PubMed 28121932
- Onco Targets Ther, 2015 (first author): Prognostic significance of neutrophil-to- lymphocyte ratio in esophageal cancer: a meta-analysis. PubMed 25914549
- Int J Clin Exp Med, 2014 (first author): Is there an association between ABO blood group and overall survival in patients with esophageal squamous cell carcinoma?. PubMed 25232410
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion